{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T17:29:53Z","timestamp":1790702993239,"version":"4.1.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,12]],"date-time":"2022-10-12T00:00:00Z","timestamp":1665532800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008966","name":"Soci\u00e9t\u00e9 Francophone du Diab\u00e8te","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008966","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009406","name":"CHU Nantes","doi-asserted-by":"publisher","award":["RC17_0470"],"award-info":[{"award-number":["RC17_0470"]}],"id":[{"id":"10.13039\/501100009406","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004711","name":"Chung Hua University","doi-asserted-by":"publisher","award":["F\\u201044093"],"award-info":[{"award-number":["F\\u201044093"]}],"id":[{"id":"10.13039\/501100004711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004711","name":"Chung Hua University","doi-asserted-by":"publisher","award":["BB\\u20100033\\u201000040"],"award-info":[{"award-number":["BB\\u20100033\\u201000040"]}],"id":[{"id":"10.13039\/501100004711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["MP0022856"],"award-info":[{"award-number":["MP0022856"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006022","name":"French Government Ministry of Social Affairs Health and Womens Rights","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006022","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014184","name":"R\u00e9gion Occitanie Pyr\u00e9n\u00e9es-M\u00e9diterran\u00e9e","doi-asserted-by":"publisher","award":["19014226"],"award-info":[{"award-number":["19014226"]}],"id":[{"id":"10.13039\/501100014184","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes &amp; Metabolism"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.diabet.2022.101391","type":"journal-article","created":{"date-parts":[[2022,9,26]],"date-time":"2022-09-26T05:51:43Z","timestamp":1664171503000},"page":"101391","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Plasma level of ATPase inhibitory factor 1 (IF1) is associated with type 2 diabetes risk in humans: A prospective cohort study"],"prefix":"10.1016","volume":"49","author":[{"given":"Julie","family":"Pires Da Silva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthieu","family":"Wargny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00e9my","family":"Raffin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mika\u00ebl","family":"Croyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thibaut","family":"Duparc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Combes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annelise","family":"Genoux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertrand","family":"Perret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Vellas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Guyonnet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Thalamas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Langin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9dric","family":"Moro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Viguerie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves","family":"Rolland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipe de Souto","family":"Barreto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertrand","family":"Cariou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0985-3152","authenticated-orcid":false,"given":"Laurent O.","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diabet.2022.101391_bib0001","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1530\/EC-14-0092","article-title":"Mitochondrial dysfunction and insulin resistance: an update","volume":"4","author":"Montgomery","year":"2015","journal-title":"Endocr Connect"},{"key":"10.1016\/j.diabet.2022.101391_bib0002","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.redox.2017.01.013","article-title":"Mitochondrial dynamics in type 2 diabetes: pathophysiological implications","volume":"11","author":"Rovira-Llopis","year":"2017","journal-title":"Redox Biol"},{"key":"10.1016\/j.diabet.2022.101391_bib0003","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.1007\/s00125-015-3772-8","article-title":"Impaired mitochondrial oxidative phosphorylation and supercomplex assembly in rectus abdominis muscle of diabetic obese individuals","volume":"58","author":"Antoun","year":"2015","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabet.2022.101391_bib0004","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1089\/ars.2009.2531","article-title":"Mitochondrial dysfunction in diabetes: from molecular mechanisms to functional significance and therapeutic opportunities","volume":"12","author":"Sivitz","year":"2010","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.diabet.2022.101391_bib0005","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1126\/science.1082889","article-title":"Mitochondrial dysfunction in the elderly: possible role in insulin resistance","volume":"300","author":"Petersen","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.diabet.2022.101391_bib0006","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1056\/NEJMoa031314","article-title":"Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes","volume":"350","author":"Petersen","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diabet.2022.101391_bib0007","doi-asserted-by":"crossref","first-page":"2944","DOI":"10.2337\/diabetes.51.10.2944","article-title":"Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes","volume":"51","author":"Kelley","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.diabet.2022.101391_bib0008","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/414807a","article-title":"Mitochondrial function in normal and diabetic \u03b2-cells","volume":"414","author":"Maechler","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.diabet.2022.101391_bib0009","doi-asserted-by":"crossref","DOI":"10.1089\/ars.2021.0137","article-title":"The multifaceted ATPase inhibitory factor 1 (IF1) in energy metabolism reprogramming and mitochondrial dysfunction: a new player in age-associated disorders?","author":"Gore","year":"2022","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.diabet.2022.101391_bib0010","doi-asserted-by":"crossref","first-page":"e23949","DOI":"10.1371\/journal.pone.0023949","article-title":"Mitochondrial Inhibitory Factor 1 (IF1) is present in human serum and is positively correlated with HDL-cholesterol","volume":"6","author":"Genoux","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.diabet.2022.101391_bib0011","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1194\/jlr.P036335","article-title":"Serum IF1 concentration is independently associated to HDL levels and to coronary heart disease: the GENES study","volume":"54","author":"Genoux","year":"2013","journal-title":"J Lipid Res"},{"key":"10.1016\/j.diabet.2022.101391_bib0012","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/s12916-016-0672-9","article-title":"Serum levels of mitochondrial inhibitory factor 1 are independently associated with long-term prognosis in coronary artery disease: the GENES Study","volume":"14","author":"Genoux","year":"2016","journal-title":"BMC Med"},{"key":"10.1016\/j.diabet.2022.101391_bib0013","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0221524","article-title":"Fatty liver index is a strong predictor of changes in glycemic status in people with prediabetes: the IT-DIAB study","volume":"14","author":"Wargny","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.diabet.2022.101391_bib0014","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.atherosclerosis.2019.11.027","article-title":"Circulating PCSK9 levels are not associated with the conversion to type 2 diabetes","volume":"293","author":"Ramin-Mangata","year":"2020","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.diabet.2022.101391_bib0015","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s12933-022-01452-5","article-title":"Plasma apolipoprotein concentrations and incident diabetes in subjects with prediabetes","volume":"21","author":"Croyal","year":"2022","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.diabet.2022.101391_bib0016","doi-asserted-by":"crossref","first-page":"E325","DOI":"10.1152\/ajpendo.00109.2021","article-title":"Metabolic and cardiovascular adaptations to an 8-wk lifestyle weight loss intervention in younger and older obese men","volume":"321","author":"Vion","year":"2021","journal-title":"Am J Physiol - Endocrinol Metab"},{"key":"10.1016\/j.diabet.2022.101391_bib0017","first-page":"13","article-title":"MAPT Study: a multidomain approach for preventing Alzheimer's disease: design and baseline data","volume":"1","author":"Vellas","year":"2014","journal-title":"J Prev Alzheimer's Dis"},{"key":"10.1016\/j.diabet.2022.101391_bib0018","doi-asserted-by":"crossref","DOI":"10.1093\/gerona\/glac018","article-title":"Physical activity, body mass index, and blood progranulin in older adults: cross-sectional associations in the MAPT Study","author":"Raffin","year":"2022","journal-title":"J Gerontol Ser A"},{"key":"10.1016\/j.diabet.2022.101391_bib0019","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S1474-4422(17)30040-6","article-title":"Effect of long-term omega 3 polyunsaturated fatty acid supplementation with or without multidomain intervention on cognitive function in elderly adults with memory complaints (MAPT): a randomised, placebo-controlled trial","volume":"16","author":"Andrieu","year":"2017","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.diabet.2022.101391_bib0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.talanta.2020.121300","article-title":"A reference measurement of circulating ATPase inhibitory factor 1 (IF1) in humans by LC-MS\/MS: comparison with conventional ELISA","volume":"219","author":"Genoux","year":"2020","journal-title":"Talanta"},{"key":"10.1016\/j.diabet.2022.101391_bib0021","doi-asserted-by":"crossref","DOI":"10.1194\/jlr.D120000835","article-title":"A high-throughput mass spectrometry\u2013based assay for large-scale profiling of circulating human apolipoproteins","volume":"61","author":"Blanchard","year":"2020","journal-title":"J Lipid Res"},{"key":"10.1016\/j.diabet.2022.101391_bib0022","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and \u03b2-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabet.2022.101391_bib0023","first-page":"2013","volume":"2016","year":"2016"},{"key":"10.1016\/j.diabet.2022.101391_bib0024","doi-asserted-by":"crossref","first-page":"e13268","DOI":"10.1111\/apha.13268","article-title":"Pharmacological inhibition of the F1-ATPase\/P2Y1 pathway suppresses the effect of apolipoprotein A1 on endothelial nitric oxide synthesis and vasorelaxation","volume":"226","author":"Cabou","year":"2019","journal-title":"Acta Physiol"},{"key":"10.1016\/j.diabet.2022.101391_bib0025","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/nature01250","article-title":"Ectopic beta-chain of ATP synthase is an apolipoprotein A-I receptor in hepatic HDL endocytosis","volume":"421","author":"Martinez","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.diabet.2022.101391_bib0026","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1159\/000477607","article-title":"PI3K\u03b2 plays a key role in apolipoprotein A-I-Induced endothelial cell proliferation through activation of the ecto-F1-ATPase\/P2Y1 receptors","volume":"42","author":"Castaing-Berthou","year":"2017","journal-title":"Cell Physiol Biochem"},{"key":"10.1016\/j.diabet.2022.101391_bib0027","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.bbalip.2017.05.005","article-title":"Ectopic adenine nucleotide translocase activity controls extracellular ADP levels and regulates the F1-ATPase-mediated HDL endocytosis pathway on hepatocytes","volume":"1862","author":"Cardouat","year":"2017","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.diabet.2022.101391_bib0028","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1161\/ATVBAHA.109.187997","article-title":"Stimulation of cell surface F1-ATPase activity by apolipoprotein A-I inhibits endothelial cell apoptosis and promotes proliferation","volume":"29","author":"Radojkovic","year":"2009","journal-title":"Arter Thromb Vasc Biol"},{"key":"10.1016\/j.diabet.2022.101391_bib0029","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1161\/ATVBAHA.111.238063","article-title":"The beta-chain of cell surface F0F1 ATPase modulates ApoA-I and HDL transcytosis through aortic endothelial cells","volume":"32","author":"Cavelier","year":"2012","journal-title":"Arter Thromb Vasc Biol"},{"key":"10.1016\/j.diabet.2022.101391_bib0030","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1161\/01.ATV.16.12.1430","article-title":"Relationship of plasma cholesteryl ester transfer protein to HDL cholesterol: Studies in normotriglyceridemia and moderate hypertriglyceridemia","volume":"16","author":"F\u00f6ger","year":"1996","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.diabet.2022.101391_bib0031","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1172\/JCI116683","article-title":"Hypertriglyceridemia and cholesteryl ester transfer protein interact to dramatically alter high density lipoprotein levels, particle sizes, and metabolism: studies in transgenic mice","volume":"92","author":"Hayek","year":"1993","journal-title":"J Clin Invest"},{"key":"10.1016\/j.diabet.2022.101391_bib0032","first-page":"470","article-title":"Body mass index, waist circumference, and the risk of type 2 diabetes mellitus: implications for routine clinical practice","volume":"107","author":"Feller","year":"2010","journal-title":"Dtsch Arztebl Int"},{"key":"10.1016\/j.diabet.2022.101391_bib0033","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.atherosclerosis.2019.10.021","article-title":"Adiponectin, a unique adipocyte-derived factor beyond hormones","volume":"292","author":"Maeda","year":"2020","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.diabet.2022.101391_bib0034","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2020.154171","article-title":"Sex specific effect of ATPase inhibitory factor 1 on body weight: studies in high fat diet induced obese mice and genetic association studies in humans","volume":"105","author":"Kwak","year":"2020","journal-title":"Metabolism"},{"key":"10.1016\/j.diabet.2022.101391_bib0035","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1038\/s41598-020-58411-x","article-title":"Overexpression of native IF1 downregulates glucose-stimulated insulin secretion by pancreatic INS-1E cells","volume":"10","author":"Kahancov\u00e1","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.diabet.2022.101391_bib0036","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1002\/1873-3468.12991","article-title":"Regulation of glucose-stimulated insulin secretion by ATPase Inhibitory Factor 1 (IF1)","volume":"592","author":"Kahancov\u00e1","year":"2018","journal-title":"FEBS Lett"},{"key":"10.1016\/j.diabet.2022.101391_bib0037","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41374-021-00670-x","article-title":"ATP synthase inhibitory factor subunit 1 regulates islet \u03b2-cell function via repression of mitochondrial homeostasis","volume":"102","author":"Zhang","year":"2022","journal-title":"Lab Investig"},{"key":"10.1016\/j.diabet.2022.101391_bib0038","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1007\/s00125-017-4379-z","article-title":"Mitochondrial H+-ATP synthase in human skeletal muscle: contribution to dyslipidaemia and insulin resistance","volume":"60","author":"Formentini","year":"2017","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabet.2022.101391_bib0039","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1007\/s11357-020-00287-w","article-title":"Disease-specific plasma levels of mitokines FGF21, GDF15, and Humanin in type II diabetes and Alzheimer's disease in comparison with healthy aging","volume":"43","author":"Conte","year":"2021","journal-title":"GeroScience"},{"key":"10.1016\/j.diabet.2022.101391_bib0040","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1002\/jimd.12307","article-title":"Diagnostic value of serum biomarkers FGF21 and GDF15 compared to muscle sample in mitochondrial disease","volume":"44","author":"Lehtonen","year":"2021","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.diabet.2022.101391_bib0041","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1002\/jimd.12142","article-title":"Plasma FGF-21 and GDF-15 are elevated in different inherited metabolic diseases and are not diagnostic for mitochondrial disorders","volume":"42","author":"Tsygankova","year":"2019","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.diabet.2022.101391_bib0042","doi-asserted-by":"crossref","first-page":"213","DOI":"10.4239\/wjd.v13.i3.213","article-title":"Humanin and diabetes mellitus: A review of in vitro and in vivo studies","volume":"13","author":"Boutari","year":"2022","journal-title":"World J Diabetes"},{"key":"10.1016\/j.diabet.2022.101391_bib0043","doi-asserted-by":"crossref","first-page":"e13741","DOI":"10.14814\/phy2.13741","article-title":"Empagliflozin normalizes the size and number of mitochondria and prevents reduction in mitochondrial size after myocardial infarction in diabetic hearts","volume":"6","author":"Mizuno","year":"2018","journal-title":"Physiol Rep"},{"key":"10.1016\/j.diabet.2022.101391_bib0044","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1089\/ars.2021.0019","article-title":"Does metformin modulate mitochondrial dynamics and function in type 2 diabetic patients?","volume":"35","author":"de Mara\u00f1\u00f3n","year":"2021","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.diabet.2022.101391_bib0045","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.021949","article-title":"Sglt2 inhibition on cardiac mitochondrial function: searching for a sweet spot","volume":"10","author":"Sawicki","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.diabet.2022.101391_bib0046","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1096\/fj.201800756R","article-title":"Tissue-specific expression and post-transcriptional regulation of the ATPase inhibitory factor 1 (IF1) in human and mouse tissues","volume":"33","author":"Esparza-Molt\u00f3","year":"2019","journal-title":"FASEB J"}],"container-title":["Diabetes &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1262363622000738?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1262363622000738?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T17:12:21Z","timestamp":1778519541000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1262363622000738"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["S1262363622000738"],"URL":"https:\/\/doi.org\/10.1016\/j.diabet.2022.101391","relation":{},"ISSN":["1262-3636"],"issn-type":[{"value":"1262-3636","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Plasma level of ATPase inhibitory factor 1 (IF1) is associated with type 2 diabetes risk in humans: A prospective cohort study","name":"articletitle","label":"Article Title"},{"value":"Diabetes & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabet.2022.101391","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"101391"}}